Ensysce Biosciences Inc (ENSC)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 5.89M | 3.92M | 6.36M | 3.22M | 2.71M | 5.07M | 2.8M | 9.39M |
Total Current Assets | 5.3M | 3.37M | 5.86M | 2.76M | 2.29M | 4.7M | 2.46M | 9.09M |
Cash and Equivalents | 3.15M | 1.42M | 3.83M | 1.46M | 1.12M | 3.4M | 1.04M | 4.15M |
Total Non-Current Assets | 586k | 544k | 503k | 461k | 419k | 377k | 336k | 294k |
Total Liabilities | 9.92M | 4.07M | 2.57M | 2.06M | 3.36M | 1.65M | 1.32M | 2.81M |
Total Current Liabilities | 9.47M | 3.98M | 2.52M | 2.03M | 3.33M | 1.64M | 1.31M | 2.8M |
Total Non-Current Liabilities | 590k | 91k | 48k | 30k | 26k | 17k | 10k | 3k |
Common Equity | 1,000 | 0 | 0 | 0 | 0 | 0 | 1,000 | 1,000 |
Retained Earnings | -110.93M | -113.13M | -115.36M | -118.05M | -121.56M | -124.67M | -126.64M | -125.98M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 202.43M | 204.83M | 196.51M | 12.86M | 16.42M | 5.89M | 2.71M |
Total Current Assets | 2.31M | 1.92M | 1.2M | 227k | 15.66M | 5.3M | 2.29M |
Cash and Equivalents | 2.09M | 1.66M | 1.06M | 49k | 12.27M | 3.15M | 1.12M |
Total Non-Current Assets | 5M | 5M | 5M | 5M | -8.16M | -4.03M | -651k |
Total Liabilities | 197.43M | 7.44M | 10.34M | 7.8M | 24.58M | 9.92M | 3.36M |
Total Current Liabilities | 156k | 438k | 3.34M | 261k | 16.48M | 9.47M | 3.33M |
Total Non-Current Liabilities | 197.27M | 7M | 7M | 8.33M | 12.53M | 590k | 26k |
Total Equity | 5M | 5M | 5M | 5M | -8.16M | -4.03M | -651k |
Common Equity | 1,000 | 1,000 | 1,000 | 1,000 | 2k | 1,000 | 0 |
Retained Earnings | -31k | 2.09M | 2.46M | 5M | -85.85M | -110.93M | -121.56M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.